HighTower Advisors’s Champions Oncology CSBR Stock Holding History

HighTower Advisors’s Portfolio CSBR Stock Details CSBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$210K	Hold	41,901	–	–	﹤0.01%	3518
2026 Q2	$258K	Buy	41,901 +6,743	+19%	+$40.6K	﹤0.01%	3335
2026 Q1	$202K	Hold	35,158	–	–	﹤0.01%	3474
2025 Q4	$243K	Hold	35,158	–	–	﹤0.01%	3214
2025 Q3	$228K	Hold	35,158	–	–	﹤0.01%	3261
2025 Q2	$259K	Hold	35,158	–	–	﹤0.01%	3057
2025 Q1	$305K	Sell	35,158 -4,150	-11%	-$42K	﹤0.01%	2860
2024 Q4	$337K	Hold	39,308	–	–	﹤0.01%	2799
2024 Q3	$191K	Buy	39,308 +5,000	+15%	+$23.4K	﹤0.01%	3152
2024 Q2	$178K	Hold	34,308	–	–	﹤0.01%	3064
2024 Q1	$168K	Buy	34,308 +3,070	+10%	+$18K	﹤0.01%	3035
2023 Q4	$169K	Hold	31,238	–	–	﹤0.01%	3062
2023 Q3	$194K	Hold	31,238	–	–	﹤0.01%	2925
2023 Q2	$196K	Hold	31,238	–	–	﹤0.01%	2880
2023 Q1	$126K	Hold	31,238	–	–	﹤0.01%	2886
2022 Q4	$141K	Buy	31,238 +4,771	+18%	+$31.2K	﹤0.01%	2875
2022 Q3	$199K	Hold	26,467	–	–	﹤0.01%	2615
2022 Q2	$214K	Hold	26,467	–	–	﹤0.01%	2590
2022 Q1	$215K	Hold	26,467	–	–	﹤0.01%	2782
2021 Q4	$212K	Hold	26,467	–	–	﹤0.01%	2722
2021 Q3	$270K	Buy	26,467 +7,040	+36%	+$71.6K	﹤0.01%	2487
2021 Q2	$200K	Hold	19,427	–	–	﹤0.01%	2667
2021 Q1	$220K	Buy	19,427 +2,827	+17%	+$32.8K	﹤0.01%	2531
2020 Q4	$179K	Hold	16,600	–	–	﹤0.01%	2235
2020 Q3	$154K	Hold	16,600	–	–	﹤0.01%	2156
2020 Q2	$159K	Hold	16,600	–	–	﹤0.01%	2042
2020 Q1	$123K	Hold	16,600	–	–	﹤0.01%	1913
2019 Q4	$138K	Buy	+16,600	New	+$102K	﹤0.01%	2047

Other funds holding CSBR

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

Tocqueville Asset Management New York $7.26B AUM 32.81% 1-Year Est. Return

Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $212M AUM 53.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $463B AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

HighTower Advisors's CSBR Position: Q3 2026 in Review

HighTower Advisors held its Champions Oncology (CSBR) position steady in Q3 2026 at 41,901 shares worth $210K. The position accounts for ﹤0.01% of the portfolio, ranked #3518.

HighTower Advisors first reported a position in CSBR in Q4 2019 and has held it in 28 quarters since. The position peaked at $337K in Q4 2024. 21 funds tracked by Wall St. Rank hold CSBR as of Q3 2026.

HighTower Advisors held 41,901 shares of Champions Oncology worth $210K as of Q3 2026.
HighTower Advisors left its Champions Oncology share count unchanged in Q3 2026.
Champions Oncology made up ﹤0.01% of HighTower Advisors's portfolio in Q3 2026, its #3518 holding.
HighTower Advisors first reported a position in Champions Oncology in Q4 2019 and has held it in 28 quarters since.
HighTower Advisors's Champions Oncology position peaked at $337K in Q4 2024.
21 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2026.

Based on HighTower Advisors's 13F filing for Q3 2026, filed 10 Nov 2026.